UNSPSC 51284705: Penoctonium

This classification denotes a topical anti-infective agent with the molecular formula C26H50NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5VT390WD2G, chemically known as 2-(2,2-dicyclopentylacetyl)oxyethyl-diethyl-octylazanium but generally known as penoctonium, which bears US NIH Compound Identifier 71690. European Medicines Agency schedules Penoctonium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09672MIG. The term PENOCTONIUM is an International Non-Proprietary Name.

As of Q4 2014, PENOCTONIUM remains the US FDA Preferred Term for this commodity. Penoctonium bears US NLM identifiers UMLS ID C0604630 and NCI Concept Code C87269. SMILES: CCCCCCCC[N+](CC)(CC)CCOC(=O)C(C1CCCC1)C2CCCC2.

UNSPSC 51284705 Penoctonium, a Commodity code, designates pharmaceutical active ingredients and intermediates for bulk supply to state and local health and emergency-response programs. The recent state and local opportunities tagged under this code reflect direct procurement of finished pharmaceutical products—specifically antibiotics and opioid-antagonist medications—rather than raw chemical compounds, indicating a mismatch between the code's nominal scope and the actual work being solicited. State and local health departments and county public-health authorities are the primary issuing bodies, typically purchasing through cooperative-buying vehicles or competitive sealed bids to stock emergency supplies, disease-control stockpiles, or community-health programs. These agencies acquire pharmaceutical products in bulk quantities with multi-year contract terms, standard insurance and compliance requirements (E-Verify, drug-free workplace certification), and quarterly or as-needed delivery schedules to fixed locations.

Activity under this code appears sparse. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under IFB 26-482DPH-PREPD-B-53392, with an initial 12-month term and two renewal options. Seminole County, Florida issued an IFB (IFB60459723LAS) with a July 26, 2023 deadline for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the county's community health building in Sanford. The code shows recent procurement activity in Florida and Illinois; however, the disconnect between the code's chemical-ingredient classification and the state and local practice of purchasing finished pharmaceuticals suggests this code may not be reliably used across all jurisdictions for pharmaceutical procurement, and broader activity may be tagged elsewhere.